Zhejiang Hisoar Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 804.53 million compared to CNY 642.31 million a year ago. Revenue was CNY 804.53 million compared to CNY 642.31 million a year ago. Net income was CNY 87.02 million compared to CNY 57.19 million a year ago. Basic earnings per share from continuing operations was CNY 0.05 compared to CNY 0.04 a year ago. Diluted earnings per share from continuing operations was CNY 0.05 compared to CNY 0.04 a year ago.